Allergan (AGN) News Today → The Best AI Stock to Own in the World Today is Trading for Just $25 (From Banyan Hill Publishing) (Ad) Free AGN Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineAllergan Aesthetics and University Lab Partners Announce the Golden Ticket Pitch Competition to Accelerate Aesthetics Start-Upsfinance.yahoo.com - April 11 at 8:36 PMAllergan Aesthetics Announces the Return of CoolMonth with CoolSculptinguk.investing.com - April 5 at 7:20 AMAllergan Aesthetics Launches "Moving the Needle on Ethics" to Elevate the Conversation Around Ethics in Aestheticsfinance.yahoo.com - March 26 at 2:41 AMDr. Ran Y. Rubinstein Has Been Named Top 500 Allergan Aesthetic 2024finance.yahoo.com - February 28 at 2:09 PM6 reasons to buy Teva Pharmaceuticals stock sooner than later (AGN)marketbeat.com - February 26 at 6:20 AMPro Research: Wall Street eyes AbbVie's growth and pipeline potentialin.investing.com - January 23 at 10:25 AMAllē by Allergan Aesthetics is the Leading Aesthetics Loyalty Rewards Program in the U.S.finance.yahoo.com - January 23 at 10:25 AMBodyLase® Med Spa Ends 2023 Among Top 50 Allergan Providersfinance.yahoo.com - January 18 at 1:57 PMBotox rival Revance loses bid to dismiss Allergan trade secrets lawsuitreuters.com - January 4 at 1:52 PMPro Research: Wall Street explores AbbVie's market dynamicsza.investing.com - December 29 at 3:27 AMPro Research: wall street dives into abbvie's growth potentialza.investing.com - December 26 at 5:25 PMDr. Ran Y. Rubinstein: Revolutionizing Aesthetics for 18 Years as an Expert Allergan and Galderma Trainerfinance.yahoo.com - December 19 at 1:21 PMAllergan Announces Positive Results From Phase 3 Studies Of TrenibotulinumtoxinE In Glabella Linesmarkets.businessinsider.com - October 24 at 9:32 AMAllergan Aesthetics Supports Breast Cancer Patients and Celebrates Breast Reconstruction Patients Through The Reblossom Projectfinance.yahoo.com - October 19 at 9:03 AMAllergan Aesthetics and University Lab Partners Announce the Golden Passport Pitch Competition to Accelerate Aesthetics Start-Upsfinance.yahoo.com - October 18 at 12:25 AMUnlocking Vision Wellness: Allergan’s Media Conclave On World Sight Day Spotlights Eyecare's Crucial Role In Modern Workplacemsn.com - October 10 at 2:29 PMAllergan (AGN), Pfizer in Advanced Takeover Talks, Stocks Fall, Jim Cramer Weighs Inthestreet.com - September 15 at 6:28 PMBausch + Lomb's Saunders doesn't expect more big deals in the near termca.investing.com - August 2 at 10:02 PMBausch + Lomb posts better than expected Q2 earningsza.investing.com - August 2 at 10:21 AMAllergan Aesthetics Announces First Ever JUVÉDERM® Dayfinance.yahoo.com - August 1 at 7:19 PMWhy Valeant Pharmaceuticals (VRX) Stock Is Upthestreet.com - July 24 at 7:48 AMCramer -- Why a Pfizer Merger With Allergan Makes Sensethestreet.com - July 7 at 5:43 PMN.C. to receive $521M in opioid settlements with Teva, Allergan, CVS and Walgreensmsn.com - June 9 at 5:04 PMVirginia receives $365.6 million in opioid settlements with Teva, Allergan, CVS, and Walgreensmsn.com - June 9 at 5:04 PMPfizer (PFE) Stock Sinks, Negotiating Break-Up Fee in Allergan Deal, Jim Cramer's Viewthestreet.com - May 22 at 3:32 PMBipolar Disorder Therapeutics Market Size, Growth Opportunities, Future Trends and Share with Revenue Forecast 2028marketwatch.com - May 17 at 3:47 PMVirios Therapeutics Up 75% on Fibromyalgia Phase 3 Proposal (AGN)marketbeat.com - April 25 at 11:30 AMBiogen (BIIB) Stock Declines in After-Hours, Allergan Unlikely to Pursue Takeoverthestreet.com - March 7 at 11:14 AMIs the Pain Over for Baudax Bio Investors after a 70% Spike? (AGN)marketbeat.com - January 25 at 4:00 AMAllergan Aesthetics and Girls Inc. Partner to Bridge the Gender Gap in STEM - Yahoo Financefinance.yahoo.com - October 19 at 8:52 PMWomen sue over Allergan breast implants | Ireland | The Sunday Times - The Timesthetimes.co.uk - October 15 at 11:22 PMAllergan Aesthetics Pledges Diamond Level Sponsorship for 2022 Breast Reconstruction Awareness Day - Yahoo Financefinance.yahoo.com - October 12 at 7:51 PMNew Paris bakery specializes in allergen-free foods - Yahoo Newsnews.yahoo.com - October 11 at 8:14 PMOutlook on the Male Hypogonadism Global Market to 2030 - Featuring Allergan, Pfizer, Bayer and Endo Inter - Benzingabenzinga.com - October 11 at 10:10 AMOcular Implant Market Report (2022 to 2030) - Johnson and Johnson Services Inc., Carl Zeiss AG, Glaukos Corporation, Morcher GmbH, Allergan Inc. and Hoya Corporation - GlobeNewswireglobenewswire.com - October 11 at 10:10 AMIn Her Own Words: Nicci Levy's ALCHEMY 43 focuses on faces - Bizwomen - The Business Journalsbizjournals.com - October 9 at 2:20 PMAllergan Aesthetics to Present Data from Its Leading Aesthetic Portfolio at the 2022 American Society for Dermatologic Surgery Meeting - Yahoo Financefinance.yahoo.com - October 7 at 9:06 PMAllergan Aesthetics to Present Data from Its Leading Aesthetic Portfolio at the 2022 American Society for Dermatologic Surgery Meeting - PR Newswireprnewswire.com - October 7 at 4:05 PMGlobal Acne Treatment Market (2022 Edition)– Analysis By Treatment, Treatment Modality, End-Users, By Region, By Country: Market Insights and Forecast with Impact of COVID-19 (2023-2028) - GlobeNewswireglobenewswire.com - October 7 at 12:24 AMThe Global Botulinum Toxin Market size is expected to reach $10.5 billion by 2028, rising at a market growth of 10.8% CAGR during the forecast period - Yahoo Financefinance.yahoo.com - October 4 at 10:13 PMGlobal Glaucoma Treatment Market Report 2022: Featuring Pfizer, F. Hoffmann-La Roche, Merck, Allergan & Others - ResearchAndMarkets.com - Business Wirebusinesswire.com - October 4 at 12:12 PMCan AbbVie's (ABBV) New Drugs Make up for Lost Humira Sales? - Nasdaqnasdaq.com - October 3 at 5:56 PMGlobal Dry Eye Syndrome Therapeutics Market Report to 2029 - Featuring Abbott, AbbVie, Allergan and AstraZeneca Among Others - ResearchAndMarkets.com - Business Wirebusinesswire.com - October 3 at 12:56 PMHow Far Will AbbVie's Humira Revenue Fall in 2023? - TheStreetthestreet.com - October 1 at 7:11 PMIs AbbVie a Buy? - Nasdaqnasdaq.com - September 24 at 9:50 AMHyaluronic Acid-based Dermal Fillers Global Market Report 2022 - Benzingabenzinga.com - September 23 at 11:49 PMThe Forces of Beauty® Report from The DREAM Initiative® Reveals Demand for New Standards of Beauty and Imagery - PR Newswireprnewswire.com - September 23 at 1:49 PMEvolus Concludes Certain Royalty Payments; Financial Profile Improves Significantly Starting in the Fourth Quarter of 2022 - Business Wirebusinesswire.com - September 21 at 8:56 AMFCA's 'Creative Lawyering' Defense Divides Full 4th Circ. - Law360law360.com - September 16 at 7:17 AMThe House That Botox Built: Ex-Allergan CEO Lists Miami Home for $21.9 Million - The Wall Street Journalwsj.com - September 13 at 7:48 PM Get Allergan News Delivered to You Automatically Sign up to receive the latest news and ratings for AGN and its competitors with MarketBeat's FREE daily newsletter. Email Address At first glance, this chart looks like nonsense… (Ad)We can isolate the most bullish dates to buy Netflix each and every year… That’s why one former hedge fund manager calls these dates… “Hotspot Dates” But if you want the stock with “Hotspot Dates” hitting NEXT WEEK… AGN Media Mentions By Week AGN Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AGN News Sentiment▼0.000.48▲Average Medical News Sentiment AGN News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AGN Articles This Week▼00▲AGN Articles Average Week Get Allergan News Delivered to You Automatically Sign up to receive the latest news and ratings for AGN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Zoetis News Today Bristol-Myers Squibb News Today Royalty Pharma News Today BeiGene News Today Jazz Pharmaceuticals News Today Apellis Pharmaceuticals News Today Glaukos News Today Bausch Health Companies News Today Akero Therapeutics News Today Mirum Pharmaceuticals News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:AGN) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThe A.I. story nobody is telling you (Read ASAP)TradeSmithHealthcare Takes A Big Step Forward With The Help Of AIThe Bull Reporttop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap Profits[Shocking] Elon Musk’s Plan To End BanksCrypto 101 MediaUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Allergan plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
